Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease

Jeremy P Dwyer, Arshad Javed, Christopher S Hair, Gregory Thomas Charles Moore

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

BACKGROUND: Venous thromboembolism (VTE) is a well-recognised extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite the widespread support for anticoagulant prophylaxis in hospitalised IBD patients, the utilisation and efficacy in clinical practice are unknown. AIMS: The aim of this study was to assess the prevalence and clinical features of VTE among hospitalised IBD patients and ascertain whether appropriate thromboprophylaxis had been administered. METHODS: All patients with a discharge diagnosis of Crohn disease or ulcerative colitis and VTE were retrospectively identified using International Classification of Diseases, tenth revision codes from medical records at our institution from July 1998 to December 2009. Medical records were then reviewed for clinical history and utilisation of thromboprophylaxis. Statistical analysis was performed by Mann-Whitney test and either chi(2) tests or Fisher s exact tests. RESULTS: Twenty-nine of 3758 (0.8 ) IBD admissions suffered VTE, 13 preadmission and 16 during admission. Of these 29 admissions (in 25 patients), 24 required intensive care unit and 10 died. Of the 16 venous thrombotic events that occurred during an admission, eight (50 ) did not receive anticoagulant thromboprophylaxis and eight (50 ) occurred despite thromboprophylaxis. Most thromboembolism despite prophylaxis occurred post-intestinal resection (n = 5, 63 ). CONCLUSION: Thromboprophylaxis is underutilised in half of IBD patients suffering VTE. Prescription of thromboprophylaxis for all hospitalised IBD patients, including dual pharmacological and mechanical prophylaxis in postoperative patients, may lead to a reduction in this preventable complication of IBD.
Original languageEnglish
Pages (from-to)779 - 784
Number of pages6
JournalInternal Medicine Journal
Volume44
Issue number8
DOIs
Publication statusPublished - 2014

Cite this

@article{691c07547c61447f9343270990199ff0,
title = "Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease",
abstract = "BACKGROUND: Venous thromboembolism (VTE) is a well-recognised extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite the widespread support for anticoagulant prophylaxis in hospitalised IBD patients, the utilisation and efficacy in clinical practice are unknown. AIMS: The aim of this study was to assess the prevalence and clinical features of VTE among hospitalised IBD patients and ascertain whether appropriate thromboprophylaxis had been administered. METHODS: All patients with a discharge diagnosis of Crohn disease or ulcerative colitis and VTE were retrospectively identified using International Classification of Diseases, tenth revision codes from medical records at our institution from July 1998 to December 2009. Medical records were then reviewed for clinical history and utilisation of thromboprophylaxis. Statistical analysis was performed by Mann-Whitney test and either chi(2) tests or Fisher s exact tests. RESULTS: Twenty-nine of 3758 (0.8 ) IBD admissions suffered VTE, 13 preadmission and 16 during admission. Of these 29 admissions (in 25 patients), 24 required intensive care unit and 10 died. Of the 16 venous thrombotic events that occurred during an admission, eight (50 ) did not receive anticoagulant thromboprophylaxis and eight (50 ) occurred despite thromboprophylaxis. Most thromboembolism despite prophylaxis occurred post-intestinal resection (n = 5, 63 ). CONCLUSION: Thromboprophylaxis is underutilised in half of IBD patients suffering VTE. Prescription of thromboprophylaxis for all hospitalised IBD patients, including dual pharmacological and mechanical prophylaxis in postoperative patients, may lead to a reduction in this preventable complication of IBD.",
author = "Dwyer, {Jeremy P} and Arshad Javed and Hair, {Christopher S} and Moore, {Gregory Thomas Charles}",
year = "2014",
doi = "10.1111/imj.12488",
language = "English",
volume = "44",
pages = "779 -- 784",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "8",

}

Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease. / Dwyer, Jeremy P; Javed, Arshad; Hair, Christopher S; Moore, Gregory Thomas Charles.

In: Internal Medicine Journal, Vol. 44, No. 8, 2014, p. 779 - 784.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease

AU - Dwyer, Jeremy P

AU - Javed, Arshad

AU - Hair, Christopher S

AU - Moore, Gregory Thomas Charles

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Venous thromboembolism (VTE) is a well-recognised extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite the widespread support for anticoagulant prophylaxis in hospitalised IBD patients, the utilisation and efficacy in clinical practice are unknown. AIMS: The aim of this study was to assess the prevalence and clinical features of VTE among hospitalised IBD patients and ascertain whether appropriate thromboprophylaxis had been administered. METHODS: All patients with a discharge diagnosis of Crohn disease or ulcerative colitis and VTE were retrospectively identified using International Classification of Diseases, tenth revision codes from medical records at our institution from July 1998 to December 2009. Medical records were then reviewed for clinical history and utilisation of thromboprophylaxis. Statistical analysis was performed by Mann-Whitney test and either chi(2) tests or Fisher s exact tests. RESULTS: Twenty-nine of 3758 (0.8 ) IBD admissions suffered VTE, 13 preadmission and 16 during admission. Of these 29 admissions (in 25 patients), 24 required intensive care unit and 10 died. Of the 16 venous thrombotic events that occurred during an admission, eight (50 ) did not receive anticoagulant thromboprophylaxis and eight (50 ) occurred despite thromboprophylaxis. Most thromboembolism despite prophylaxis occurred post-intestinal resection (n = 5, 63 ). CONCLUSION: Thromboprophylaxis is underutilised in half of IBD patients suffering VTE. Prescription of thromboprophylaxis for all hospitalised IBD patients, including dual pharmacological and mechanical prophylaxis in postoperative patients, may lead to a reduction in this preventable complication of IBD.

AB - BACKGROUND: Venous thromboembolism (VTE) is a well-recognised extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite the widespread support for anticoagulant prophylaxis in hospitalised IBD patients, the utilisation and efficacy in clinical practice are unknown. AIMS: The aim of this study was to assess the prevalence and clinical features of VTE among hospitalised IBD patients and ascertain whether appropriate thromboprophylaxis had been administered. METHODS: All patients with a discharge diagnosis of Crohn disease or ulcerative colitis and VTE were retrospectively identified using International Classification of Diseases, tenth revision codes from medical records at our institution from July 1998 to December 2009. Medical records were then reviewed for clinical history and utilisation of thromboprophylaxis. Statistical analysis was performed by Mann-Whitney test and either chi(2) tests or Fisher s exact tests. RESULTS: Twenty-nine of 3758 (0.8 ) IBD admissions suffered VTE, 13 preadmission and 16 during admission. Of these 29 admissions (in 25 patients), 24 required intensive care unit and 10 died. Of the 16 venous thrombotic events that occurred during an admission, eight (50 ) did not receive anticoagulant thromboprophylaxis and eight (50 ) occurred despite thromboprophylaxis. Most thromboembolism despite prophylaxis occurred post-intestinal resection (n = 5, 63 ). CONCLUSION: Thromboprophylaxis is underutilised in half of IBD patients suffering VTE. Prescription of thromboprophylaxis for all hospitalised IBD patients, including dual pharmacological and mechanical prophylaxis in postoperative patients, may lead to a reduction in this preventable complication of IBD.

UR - http://onlinelibrary.wiley.com/doi/10.1111/imj.12488/pdf

U2 - 10.1111/imj.12488

DO - 10.1111/imj.12488

M3 - Article

VL - 44

SP - 779

EP - 784

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 8

ER -